UMIN ID: UMIN000021309
Registered date:03/03/2016
Assessment of the safety of nicotinamide mononucleotide (NMN) in healthy subjects; phase I study. The clinical trial to evaluate metabolic-syndrome-related parameters to develop NMN as Foods with Function Claims.
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | healthy subjects |
Date of first enrollment | 2016/03/09 |
Target sample size | 10 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | the single intake of NMN. |
Outcome(s)
Primary Outcome | the safety of NMN (physical and laboratory examinations). |
---|---|
Secondary Outcome | the kinetics of NMN. |
Key inclusion & exclusion criteria
Age minimum | 40years-old |
---|---|
Age maximum | 60years-old |
Gender | Male |
Include criteria | |
Exclude criteria | 1 the subjects with a previous history of diseases. 2 the subjects with malignant neoplasms. 3 the subjects with serious infections. 4 the subjects with psychiatric disorders. 5 the subjects with ophthalmic disorder. 6 the subjects with allergic disorders. 7 the subjects who are regarded as inadequate by the investigator. |
Related Information
Primary Sponsor | Keio University School of Medicine |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Keio University |
Secondary ID(s) |
Contact
public contact | |
Name | Junichiro Irie |
Address | 35 Shinanomachi, Shinjuku, Tokyo, JAPAN Japan 1608582 |
Telephone | 03-5363-3797 |
j-irie@z8.keio.jp | |
Affiliation | Keio University School of Medicine Division of Endocrinology, Metabolism and Nephrology |
scientific contact | |
Name | Hiroshi Itoh |
Address | 35 Shinanomachi, Shinjuku, Tokyo, JAPAN Japan |
Telephone | 03-5363-3797 |
hiito@z8.keio.jp | |
Affiliation | Keio University School of Medicine Division of Endocrinology, Metabolism and Nephrology |